| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e469f4f542d6d430759ed1bd1366b062
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_41937f262a483abf5477f535e5945be6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3cbe5f7fbdbafa5667463871dfe9fae3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f186daf659d63052764813f63d79448d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4da7eb2611eb394ab1e77bdb53c8b392
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5a0f0af57f1ffa8080e0af5749304906 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S436-815 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-9453
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5308 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543 |
| filingDate |
2011-11-22^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-10-23^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d70866a44c363f60437edcaafe2f6ee3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2335afc903e6c6e38f01af5cc3a38b3b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d25133cf772cafab5d03b386f722e61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64df029048c6ad908d864746ef18bc6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93a611c5dd4a5742d4e6433ca7cca6c7 |
| publicationDate |
2012-10-23^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8293492-B2 |
| titleOfInvention |
Lenalidomide and thalidomide immunoassays |
| abstract |
Novel conjugates and immunogens derived from lenalidomide and antibodies generated by these immunogens are useful in immunoassays for the quantification and monitoring of thalidomide and lenalidomide in biological fluids. |
| priorityDate |
2010-03-12^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |